Biotech FivePrime Therapeutics, Inc. Files for a $60 Million IPO
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
Five Prime Therapeutics, an early clinical stage biotech developing protein therapeutics, filed on Friday with the SEC to raise up to $60 million in an initial public offering. Its backers include Pfizer (13.7% pre-IPO stake), Advanced Technology Ventures (9.1%), Domain Associates (9.1%), HealthCap (9.1%), KPCB (9.1%), Texas Pacific Group (9.1%), Versant Ventures (9.1%) and GSK (6.3%).
Help employers find you! Check out all the jobs and post your resume.
Five Prime Therapeutics, an early clinical stage biotech developing protein therapeutics, filed on Friday with the SEC to raise up to $60 million in an initial public offering. Its backers include Pfizer (13.7% pre-IPO stake), Advanced Technology Ventures (9.1%), Domain Associates (9.1%), HealthCap (9.1%), KPCB (9.1%), Texas Pacific Group (9.1%), Versant Ventures (9.1%) and GSK (6.3%).
Help employers find you! Check out all the jobs and post your resume.